Rhenman & Partners Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-221,255	Closed	-$8.61M	–	94
2023 Q1	$8.61M	Buy	221,255 +25,384	+13%	+$988K	0.95%	35
2022 Q4	$10.4M	Buy	195,871 +40,871	+26%	+$2.16M	1.08%	34
2022 Q3	$6.83M	Sell	155,000 -20,000	-11%	-$882K	0.72%	50
2022 Q2	$6.37M	Buy	175,000 +25,000	+17%	+$910K	0.72%	46
2022 Q1	$6.19M	Sell	150,000 -50,000	-25%	-$2.06M	0.61%	55
2021 Q4	$8.66M	Buy	200,000 +54,000	+37%	+$2.34M	0.58%	58
2021 Q3	$8.03M	Hold	146,000	–	–	0.56%	54
2021 Q2	$6.99M	Hold	146,000	–	–	0.47%	69
2021 Q1	$7.4M	Buy	146,000 +21,000	+17%	+$1.06M	0.52%	59
2020 Q4	$7.87M	Sell	125,000 -15,000	-11%	-$945K	0.64%	55
2020 Q3	$9.41M	Hold	140,000	–	–	0.84%	47
2020 Q2	$5.87M	Sell	140,000 -35,000	-20%	-$1.47M	0.63%	57
2020 Q1	$5.51M	Sell	175,000 -34,381	-16%	-$1.08M	0.77%	49
2019 Q4	$8.46M	Buy	209,381 +84,381	+68%	+$3.41M	0.93%	47
2019 Q3	$4.07M	Buy	+125,000	New	+$4.07M	0.51%	61